{
    "title": "Roche to buy U.S. cancer drugmaker Ignyta for $1.7 bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5204921/Roche-buy-U-S-cancer-drugmaker-Ignyta-1-7-bln.html",
    "date": "2017-12-22",
    "keywords": [
        "roche",
        "deal",
        "ignyta",
        "cancer",
        "drug",
        "oncology",
        "portfolio",
        "percent",
        "thursday",
        "precision",
        "strategy",
        "half",
        "michael",
        "hand",
        "dec",
        "drugmaker",
        "specialist",
        "inc",
        "share",
        "premium",
        "price",
        "focus",
        "diego",
        "pivotal",
        "study",
        "company",
        "suite",
        "stage",
        "development",
        "gene",
        "therapy",
        "tumour",
        "growth",
        "disease",
        "agreement",
        "companys",
        "stock",
        "line",
        "sector",
        "average",
        "analyst",
        "nawrath",
        "speak",
        "approval",
        "blockbuster",
        "field",
        "use",
        "research",
        "note",
        "market",
        "rating",
        "bank",
        "vontobel",
        "bofa",
        "merrill",
        "lynch",
        "jp",
        "sidley",
        "austin",
        "llp",
        "latham",
        "amp",
        "counsel",
        "mishra",
        "bengaluru",
        "editing",
        "gopakumar",
        "warrier",
        "edmund",
        "blair"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}